FDA frontier model eval risks capture by first mover, warns Anka Reuel

AnkaReuel · x · 2026-09-19

Anka Reuel highlights a structural risk in an FDA frontier-model evaluation case: evaluator Accenture lacks sufficient domain expertise and must rely on Anthropic, the company being evaluated — so eval criteria risk being shaped by the first mover. The quoted reply warns Anthropic may effectively help write the evaluation protocols, a known issue in bio/medtech. Reuel calls on Accenture to publish a frontier-model evaluation for independent expert scrutiny, both to prove competence and to improve its process.

Original post →

More from Companies & People

Companies & People channel →